These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28818454)

  • 1. The anti-tumor effect of intravesical administration of normal urothelial cells on bladder cancer.
    Huang CP; Chen CC; Shyr CR
    Cytotherapy; 2017 Oct; 19(10):1233-1245. PubMed ID: 28818454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of novel intravesical xenogeneic urothelial cell immunotherapy and chemotherapy enhances anti-tumor efficacy in preclinical murine bladder tumor models.
    Huang CP; Wu CC; Shyr CR
    Cancer Immunol Immunother; 2021 May; 70(5):1419-1433. PubMed ID: 33156394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical Administration of Xenogeneic Porcine Urothelial Cells Attenuates Cyclophosphamide-Induced Cystitis in Mice.
    Huang CP; Chen CC; Tsai YT; Wu CC; Shyr CR
    Cell Transplant; 2019 Mar; 28(3):296-305. PubMed ID: 30675801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse.
    Nativ O; Dalal E; Hidas G; Aronson M
    Int J Urol; 2006 Oct; 13(10):1344-6. PubMed ID: 17010016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperprogression after anti-programmed cell death ligand-1 therapy in a patient with recurrent metastatic urothelial bladder carcinoma following first-line cisplatin-based chemotherapy: a case report.
    Mao S; Zhang J; Guo Y; Zhang Z; Wu Y; Zhang W; Wang L; Geng J; Yan Y; Yao X
    Drug Des Devel Ther; 2019; 13():291-300. PubMed ID: 30666091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravesical Anti-PD-1 Immune Checkpoint Inhibition Treats Urothelial Bladder Cancer in a Mouse Model.
    Kirschner AN; Wang J; Rajkumar-Calkins A; Neuzil KE; Chang SS
    J Urol; 2021 May; 205(5):1336-1343. PubMed ID: 33356477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular complex of bovine milk protein and oleic acid selectively kills cancer cells in vitro and inhibits tumour growth in an orthotopic rat bladder tumour model.
    Xiao Z; Mak A; Koch K; Moore RB
    BJU Int; 2013 Jul; 112(2):E201-10. PubMed ID: 23356235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of immunotherapy in urothelial carcinoma-Immunobiology/biomarkers.
    Sweis RF; Galsky MD
    Urol Oncol; 2016 Dec; 34(12):556-565. PubMed ID: 27836246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How cancer cells attach to urinary bladder epithelium in vivo: study of the early stages of tumorigenesis in an orthotopic mouse bladder tumor model.
    Erman A; Kapun G; Novak S; Pavlin M; Dražić G; Drobne D; Veranič P
    Histochem Cell Biol; 2019 Mar; 151(3):263-273. PubMed ID: 30280243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.
    Gronlund-Pakkanen S; Wahlfors J; Makinen K; Pakkanen TM; Talja M; Ala-Opas M; Alhava E; Moore RB
    J Urol; 2002 Apr; 167(4):1848-53. PubMed ID: 11912446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonviral cytokine gene therapy on an orthotopic bladder cancer model.
    Wu Q; Mahendran R; Esuvaranathan K
    Clin Cancer Res; 2003 Oct; 9(12):4522-8. PubMed ID: 14555526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model.
    Chade DC; Andrade PM; Borra RC; Leite KR; Andrade E; Villanova FE; Srougi M
    Int Braz J Urol; 2008; 34(2):220-6; discussion 226-9. PubMed ID: 18462521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
    Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant bacillus Calmette-Guérin in urothelial bladder cancer immunotherapy: current strategies.
    Wang Y; Yang M; Yu Q; Yu L; Shao S; Wang X
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):85-93. PubMed ID: 25231670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo retroviral mediated gene transfer into bladder urothelium results in preferential transduction of tumoral cells.
    Dumey N; Mongiat-Artus P; Devauchelle P; Lesourd A; Cotard JP; Le Duc A; Marty M; Cussenot O; Cohen-Haguenauer O
    Eur Urol; 2005 Feb; 47(2):257-63. PubMed ID: 15661423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.
    Di Stasi SM; Valenti M; Verri C; Liberati E; Giurioli A; Leprini G; Masedu F; Ricci AR; Micali F; Vespasiani G
    Lancet Oncol; 2011 Sep; 12(9):871-9. PubMed ID: 21831711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical application of rebamipide promotes urothelial healing in a rat cystitis model.
    Funahashi Y; Yoshida M; Yamamoto T; Majima T; Takai S; Gotoh M
    J Urol; 2014 Dec; 192(6):1864-70. PubMed ID: 24992331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies.
    Watanabe T; Shinohara N; Sazawa A; Harabayashi T; Ogiso Y; Koyanagi T; Takiguchi M; Hashimoto A; Kuzumaki N; Yamashita M; Tanaka M; Grossman HB; Benedict WF
    Cancer Gene Ther; 2000 Dec; 7(12):1575-80. PubMed ID: 11228536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-31 functions as a tumor suppressor and increases sensitivity to mitomycin-C in urothelial bladder cancer by targeting integrin α5.
    Xu T; Qin L; Zhu Z; Wang X; Liu Y; Fan Y; Zhong S; Wang X; Zhang X; Xia L; Zhang X; Xu C; Shen Z
    Oncotarget; 2016 May; 7(19):27445-57. PubMed ID: 27050274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.